John Chalmers
Director/Board Member bij Prognomix, Inc.
Profiel
John Chalmers is currently a Director at Prognomix, Inc. He previously held positions as Chairman & President at National Health & Medical Research Council and International Society of Hypertension, Principal at Royal Prince Alfred Hospital and Massachusetts Institute of Technology.
He received a doctorate degree from The University of New South Wales in 1967 and an undergraduate degree from The University of Sydney in 1963.
Actieve functies van John Chalmers
| Bedrijven | Functie | Begin |
|---|---|---|
Prognomix, Inc.
 Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Eerdere bekende functies van John Chalmers
| Bedrijven | Functie | Einde |
|---|---|---|
International Society of Hypertension
 International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Chairman | - |
Royal Prince Alfred Hospital
 Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
| National Health & Medical Research Council | Chairman | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
Opleiding van John Chalmers
| The University of New South Wales | Doctorate Degree |
| The University of Sydney | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Royal Prince Alfred Hospital
Royal Prince Alfred Hospital Hospital/Nursing ManagementHealth Services Royal Prince Alfred Hospital provides general medical and surgical services. The company was founded in 1882 and is headquartered in Sydney, Australia. | Health Services |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
| National Health & Medical Research Council | Government |
International Society of Hypertension
International Society of Hypertension Miscellaneous Commercial ServicesCommercial Services The International Society of Hypertension (ISH) was established in 1966 and is committed to promoting and encouraging the advancement of hypertension research. The non-profit company is based in Hampton Hill, UK. The ISH Women in Hypertension Research Committee focuses on improving care for women with hypertension worldwide. Professor Bryan Williams has been announced as the next President of the ISH for the years 2022-2024. | Commercial Services |
